ReportsMonitor has added a report on Dermatology Drugs Market.
Dermatology drugs are used to treat various skin conditions. A large number of drugs have been authorized by the FDA and other regulative bodies of various nations for several skin conditions and disorders. The dermatological indications such as pigmentation, acne, wrinkles, psoriasis and many other can be treated by the dermatology drugs. Dermatology drugs market is witnessing significant growth in the recent past. However, during the 2008 -09 recession, this market was hard hit, when it given its reliance on disposable consumer income.
If you want sample of this Report –
https://www.reportsmonitor.com/request-sample/?post=294805
Summary
Dermatology is a highly diverse therapy area that deals with diseases of the skin, hair and nails. Over 3,000 types of dermatological conditions are thought to exist, ranging from the autoimmune disorder psoriasis to the very common condition acne vulgaris. The scope of dermatological disorders is diverse in terms of severity and clinical presentation, and if a condition is not sufficiently kept under control, it can significantly impair the patient?s quality of life.
The treatment landscape for dermatological disorders was traditionally dominated by genericized topical therapies such as glucocorticoids and retinoids. The approval of monoclonal antibodies (mAbs) such as Humira, Enbrel and Remicade for psoriasis revolutionized both the management of psoriasis and the dermatology therapy area. These first generation mAbs are now off-patent and have biosimilar versions approved by the FDA, but in recent years the therapy area has seen a number of new mAbs enter the market.
Scope
– Global revenue from the dermatology market is forecast to increase from $19.8 billion in 2016 to $36.6 billion in 2023, at a compound annual growth rate of 9.13%. Which drugs will achieve blockbuster status and how will the key player companies perform during the forecast period?
– What are the leading companies in terms of market share?
– Which companies are forecast to experience the largest growth in market share?
– Which companies rely heavily on revenue derived from antibacterial drugs?
– How will the market respond to recent approvals?
Reasons to buy
– Understand the current treatment landscape, with portfolios of key marketed products and a focus on historical and forecast sales patterns, and an overview of each drug?s mechanism of action.
– Analyze the dermatology pipeline through a comprehensive review of the pipeline segmented by stage of development, molecule type and molecular target.
– This review also provides a detailed look at dermatology product clinical trials to provide an insight into the risk associated with attempting to bring pipeline products to market.
If you want to check Discount on this Report –
https://www.reportsmonitor.com/check-discount/?post=294805
Table Of Contents
Global Dermatology Drugs Market
1 Table of Contents1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 10
2.1 Therapy Area Introduction 10
2.2 Symptoms 10
2.3 Etiology and Pathophysiology 11
2.3.1 Atopic Dermatitis 11
2.3.2 Acne Vulgaris 13
2.3.3 Psoriasis 14
2.4 Co-morbidities and Complications 14
2.5 Diagnosis, Scales and Grading 15
2.5.1 Atopic Dermatitis 15
2.5.2 Acne Vulgaris 16
2.5.3 Psoriasis 17
2.6 Epidemiology Patterns and Forecasts – Prevalence and Patient Segmentation 17
2.6.1 Atopic Dermatitis 18
2.6.2 Acne Vulgaris 19
2.6.3 Psoriasis 20
Continue…….
Full Report Access –
About us:
Reports Monitor is a platform to meet the market research and business intelligence requirements. Our aim is to change the dynamics of the Market Research industry by providing quality intelligence backed by data. Your requirement for market forecasting is fulfilled by our exclusive quantitative and analytics driven intelligence. Decision makers can now rely on our distinct data gathering methods to get factual market forecasting and detailed analysis.